{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:08:54Z","timestamp":1784117334478,"version":"3.55.0"},"reference-count":163,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["CVZ\u2014APQ-01591-14"],"award-info":[{"award-number":["CVZ\u2014APQ-01591-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166582","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T19:14:01Z","timestamp":1479237241000},"page":"e0166582","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Meta-Analysis and Advancement of Brucellosis Vaccinology"],"prefix":"10.1371","volume":"11","author":[{"given":"Tatiane F.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo A.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane A.","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4830-0470","authenticated-orcid":true,"given":"Renato L.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2010.06.013","article-title":"The changing Brucella<\/italic> ecology: novel reservoirs, new threats","volume":"36","author":"G Pappas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"ref2","first-page":"237","article-title":"Pathogenesis and cellular immunity in experimental murine brucellosis","volume":"56","author":"C Cheers","year":"1984","journal-title":"Dev Biol Stand"},{"key":"ref3","unstructured":"Corbel MJ. Brucellosis in Humans and Animals. WHO Press, 2006; World Health Organization, Switzerland."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1369-5274(00)00165-X","article-title":"Brucellosis: a worldwide zoonosis","volume":"4","author":"ML Boschiroli","year":"2001","journal-title":"Curr Opin Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcpa.2008.10.004","article-title":"Pathological, immunohistochemical and bacteriological study of tissues and milk of cows and fetuses experimentally infected with Brucella abortus<\/italic>","volume":"140","author":"MN Xavier","year":"2009","journal-title":"J Comp Pathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tvjl.2009.04.010","article-title":"Pathogenesis of bovine brucellosis","volume":"184","author":"AV Carvalho Neta","year":"2010","journal-title":"Vet J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.20506\/rst.32.1.2193","article-title":"Pathogenesis and pathobiology of brucellosis in livestock","volume":"32","author":"FP Poester","year":"2013","journal-title":"Rev Sci Tech\u2014OIE"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1469-0691.2010.03451.x","article-title":"The socio-ecology of zoonotic infections","volume":"17","author":"A Cascio","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1590\/S0100-736X2013000600012","article-title":"Economic losses due to bovine brucellosis in Brazil","volume":"33","author":"RL Santos","year":"2013","journal-title":"Pesq Vet Bras"},{"key":"ref10","first-page":"147","article-title":"Vaccination against Brucella<\/italic>","volume":"13","author":"P Nicoletti","year":"1990","journal-title":"Adv Biotechnol Processes"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"GG Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"ref12","first-page":"743509","article-title":"A history of the development of Brucella<\/italic> vaccines","volume":"2013","author":"ED Avila-Calder\u00f3n","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0264-410X(84)90004-5","article-title":"Vaccination of cattle with Brucella abortus<\/italic> strain 19 administered by differing routes and doses","volume":"2","author":"P Nicoletti","year":"1984","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.vaccine.2015.03.033","article-title":"Development of a dual vaccine for prevention of Brucella abortus<\/italic> infection and Escherichia coli<\/italic> O157:H7 intestinal colonization","volume":"33","author":"F Iannino","year":"2015","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"I Moriyon","year":"2004","journal-title":"Vet Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-14-S6-S3","article-title":"Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella<\/italic> vaccines and vaccine candidates","volume":"14","author":"TE Todd","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus<\/italic> infection","volume":"14","author":"SC Oliveira","year":"1996","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1128\/IAI.00331-06","article-title":"Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis<\/italic> lipopolysaccharide subunit vaccine","volume":"74","author":"AK Bhattacharjee","year":"2006","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.20506\/rst.32.1.2201","article-title":"Recent developments in livestock and wildlife brucellosis vaccination","volume":"32","author":"SC Olsen","year":"2013","journal-title":"Rev Sci Tech"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella<\/italic> lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus<\/italic> 544 independently of the adjuvant formulation used","volume":"71","author":"CA Velikovsky","year":"2003","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella<\/italic> species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus<\/italic> infection","volume":"77","author":"KA Pasquevich","year":"2009","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11259-009-9337-x","article-title":"Protection of mice against Brucella abortus<\/italic> 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides","volume":"34","author":"P Kaushik","year":"2010","journal-title":"Vet Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis<\/italic> alone or associated with rough lipopolysaccharide induces protection against Brucella ovis<\/italic> infection in BALB\/c mice","volume":"5","author":"SM Estein","year":"2003","journal-title":"Microbes Infect"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B<\/italic>. abortus<\/italic> 544","volume":"51","author":"D Goel","year":"2012","journal-title":"Mol Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-truncated Omp31 protein induces protection against Brucella<\/italic> infection in BALB\/c mice","volume":"65","author":"M Golshani","year":"2015","journal-title":"Mol Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1016\/j.vaccine.2011.04.088","article-title":"Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu\u2013Zn superoxide dismutase protein against Brucella abortus<\/italic>","volume":"29","author":"H Singha","year":"2011","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.69.10.6264-6270.2001","article-title":"Induction of immune response in BALB\/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella<\/italic> spp","volume":"69","author":"A Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1016\/j.vaccine.2007.05.049","article-title":"A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B<\/italic>. ovis<\/italic> and a similar degree of protection against B<\/italic>. melitensis<\/italic> than Rev. 1 vaccination","volume":"25","author":"J Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1656(99)00107-8","article-title":"Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines","volume":"73","author":"S Liljeqvist","year":"1999","journal-title":"J Biotechnol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.67.2.986-988.1999","article-title":"Vaccination with live Escherichia coli<\/italic> expressing Brucella abortus<\/italic> Cu\/Zn superoxide dismutase protects mice against virulent B<\/italic>. abortus<\/italic>","volume":"67","author":"AA Onate","year":"1999","journal-title":"Infect Immun"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-8518-7-1","article-title":"Evaluation of recombinant invasive, non-pathogenic Eschericia coli<\/italic> as a vaccine vector against the intracellular pathogen, Brucella<\/italic>","volume":"7","author":"JS Harms","year":"2009","journal-title":"J Immune Based Ther Vaccines"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/IAI.70.4.1915-1923.2002","article-title":"Yersinia enterocolitica<\/italic> as a vehicle for a Naked DNA vaccine encoding Brucella abortus<\/italic> bacterioferritin or p39 antigen","volume":"70","author":"A Al-Mariri","year":"2002","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","article-title":"Oral immunization of mice with recombinant Lactococcus lactis<\/italic> expressing Cu, Zn superoxide dismutase of Brucella abortus<\/italic> triggers protective immunity","volume":"30","author":"D Saez","year":"2012","journal-title":"Vaccine"},{"issue":"18","key":"ref34","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2014.02.058","article-title":"Novel influenza virus vectors expressing Brucella<\/italic> L7\/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B<\/italic>. abortus<\/italic> infection","volume":"32","author":"K Tabynov","year":"2014","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.68.6.3286-3289.2000","article-title":"Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus<\/italic> strain RB51","volume":"68","author":"R Vemulapalli","year":"2000","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/518323","article-title":"Laboratory animal models for brucellosis research","volume":"2011","author":"TMA Silva","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus<\/italic>: what the mouse model has revealed about control of infection","volume":"90","author":"CL Baldwin","year":"2002","journal-title":"Vet Microbiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.vaccine.2014.11.056","article-title":"Brucella abortus<\/italic> S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB\/c, Swiss and CD-1\u00ae) and two challenge strains (544 and 2308)","volume":"33","author":"KL Miranda","year":"2015","journal-title":"Vaccine"},{"key":"ref39","year":"2008"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus<\/italic> and Brucella melitensis<\/italic> infections","volume":"123","author":"M Abkar","year":"2015","journal-title":"APMIS"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11259-015-9645-2","article-title":"Survey of Omp19 immunogenicity against Brucella abortus<\/italic> and Brucella melitensis<\/italic>: influence of nanoparticulation versus traditional immunization","volume":"39","author":"M Abkar","year":"2015","journal-title":"Vet Res Commun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/IAI.73.7.4198-4204.2005","article-title":"Protective properties of rifampin-resistant rough mutants of Brucella melitensis<\/italic>","volume":"73","author":"R Adone","year":"2005","journal-title":"Infect Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1016\/j.vaccine.2008.07.030","article-title":"Evaluation of Brucella melitensis<\/italic> B115 as rough-phenotype vaccine against B<\/italic>. melitensis<\/italic> and B<\/italic>. ovis<\/italic> infections","volume":"26","author":"R Adone","year":"2008","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.vaccine.2011.01.072","article-title":"B<\/italic>. melitensis<\/italic> rough strain B115 is protective against heterologous Brucella<\/italic> spp. infections","volume":"29","author":"R Adone","year":"2011","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3855\/jidc.2296","article-title":"Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis<\/italic>","volume":"7","author":"A Al-Mariri","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4067\/S0301-732X2014000100008","article-title":"A DNA vaccine encoding p39 and sp41 of Brucella melitensis<\/italic> induces protective immunity in BALB\/c mice","volume":"46","author":"A Al-Mariri","year":"2014","journal-title":"Arch Med Vet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biologicals.2012.01.002","article-title":"Efficacy evaluation of live Escherichia coli<\/italic> expression Brucella<\/italic> P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis<\/italic> 16M, in BALB\/c mice","volume":"40","author":"A Al-Mariri","year":"2012","journal-title":"Biologicals"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus<\/italic> 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"A Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.vaccine.2009.12.012","article-title":"Protection of BALB\/c mice against Brucella melitensis<\/italic> 16M infection induced by vaccination with live Escherchia coli<\/italic> expression Brucella<\/italic> P39 protein","volume":"28","author":"A Al-Mariri","year":"2010","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis<\/italic> S2, Brucella melitensis<\/italic> Rev.1 and Brucella abortus<\/italic> S19 living vaccines: residual virulence and immunity induced against three Brucella<\/italic> species challenge strains in mice","volume":"8","author":"N Bosseray","year":"1990","journal-title":"Vaccine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/IAI.69.7.4528-4535.2001","article-title":"Brucella abortus<\/italic> cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells","volume":"69","author":"G Briones","year":"2001","journal-title":"Infect Immun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.imbio.2008.11.016","article-title":"Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus<\/italic> induces protective immunity in BALB\/c mice","volume":"214","author":"A Cabrera","year":"2009","journal-title":"Immunobiology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella<\/italic> outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+T helper 1 response that protects against Brucella melitensis<\/italic> infection","volume":"73","author":"J Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B<\/italic>. ovis<\/italic> than Rev.1 vaccination","volume":"25","author":"J Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella<\/italic> outer membrane protein 31 confers protection against B<\/italic>. melitensis<\/italic> and B<\/italic>. ovis<\/italic> infection by eliciting a specific cytotoxic response","volume":"73","author":"J Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis<\/italic> outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"J Cassataro","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0264-410X(01)00498-4","article-title":"Immunogenicity of the Brucella melitensis<\/italic> recombinant ribosome recycling factor-homologous protein and its cDNA","volume":"20","author":"J Cassataro","year":"2002","journal-title":"Vaccine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1099\/0022-1317-49-2-165","article-title":"Identification and partial characterisation of a new protective antigen of Brucella abortus<\/italic>","volume":"49","author":"S Cespedes","year":"2000","journal-title":"J Med Microbiol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses","volume":"79","author":"B Clapp","year":"2011","journal-title":"Infect Immun"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2013.07.041","article-title":"The vaccine candidate BLSOmp31 protects mice against Brucella canis<\/italic> infection","volume":"31","author":"M Clausse","year":"2013","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1128\/CVI.00527-14","article-title":"Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis<\/italic> in BALB\/c mice","volume":"21","author":"M Clausse","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2004.01.001","article-title":"Development and evaluation as vaccines in mice of Brucella melitensis<\/italic> Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis","volume":"22","author":"A Cloeckaert","year":"2004","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-8-5","article-title":"Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B<\/italic>. melitensis<\/italic> challenge","volume":"8","author":"NJ Commander","year":"2010","journal-title":"Genet Vaccines Ther"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis<\/italic> 16M genes","volume":"25","author":"NJ Commander","year":"2007","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"e107180","DOI":"10.1371\/journal.pone.0107180","article-title":"Oral immunization of mice with gamma-irradiated Brucella neotomae<\/italic> induces protection against intraperitoneal and intranasal challenge with virulent B<\/italic>. abortus<\/italic> 2308","volume":"9","author":"N Dabral","year":"2014","journal-title":"PlosOne"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella<\/italic> recombinant DnaK and SurA proteins induces protection against Brucella abortus<\/italic> infection in BALB\/c mice","volume":"25","author":"MV Delpino","year":"2007","journal-title":"Vaccine"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.vaccine.2006.01.038","article-title":"Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis<\/italic> in mice","volume":"24","author":"M Estevan","year":"2006","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"e29552","DOI":"10.1371\/journal.pone.0029552","article-title":"Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus<\/italic> infection","volume":"7","author":"S Fu","year":"2012","journal-title":"PlosOne"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis<\/italic> infection","volume":"32","author":"A Ghasemi","year":"2014","journal-title":"Vaccine"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis<\/italic> infection in mice","volume":"62","author":"A Ghasemi","year":"2014","journal-title":"Mol Immunol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis<\/italic> infection","volume":"33","author":"A Ghasemi","year":"2015","journal-title":"Vaccine"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus<\/italic> 544","volume":"31","author":"D Goel","year":"2013","journal-title":"Vaccine"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molimm.2015.04.015","article-title":"Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella<\/italic> L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen","volume":"66","author":"M Golshani","year":"2015","journal-title":"Mol Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","article-title":"Brucellosis vaccines: assessment of Brucella melitensis<\/italic> lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export","volume":"3","author":"D Gonz\u00e1lez","year":"2008","journal-title":"PlosOne"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imbio.2005.09.004","article-title":"Evaluation of Brucella abortus<\/italic> DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2","volume":"211","author":"A Gonzalez-Smith","year":"2006","journal-title":"Immunobiology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.vaccine.2005.12.038","article-title":"Increases of efficacy as vaccine against Brucella abortus<\/italic> infection in mice by simultaneous inoculation with avirulent smooth bvrS\/bvrR and rough wbkA mutants","volume":"24","author":"MJ Grill\u00f3","year":"2006","journal-title":"Vaccine"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0264-410X(98)00205-9","article-title":"Immunogenicity of recombinant Escherichia coli<\/italic> expressing the omp31 gene of Brucella melitensis<\/italic> in BALB\/c mice","volume":"17","author":"LA Guilloteau","year":"1999","journal-title":"Vaccine"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.rvsc.2006.07.014","article-title":"Induction of immune response in mice with a DNA vaccine encoding outer membrane protein (omp31) of Brucella melitensis<\/italic> 16M","volume":"82","author":"VK Gupta","year":"2007","journal-title":"Res Vet Sci"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-1135(02)00088-3","article-title":"Comparison between immune responses and resistance induced in BALB\/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis<\/italic> bv. 3","volume":"88","author":"MER Hamdy","year":"2002","journal-title":"Vet Microbiol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/IAI.70.5.2535-2543.2002","article-title":"Recombinant Ochrobactrum anthropi<\/italic> expressing Brucella abortus<\/italic> Cu,Zn superoxide dismutase protects mice against B<\/italic>. abortus<\/italic> infection only after switching of immune responses to Th1 type","volume":"70","author":"Y He","year":"2002","journal-title":"Infect Immun"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.vaccine.2009.12.076","article-title":"An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella<\/italic> by increasing the CD8+ cytotoxic T cell response","volume":"28","author":"XD Hu","year":"2010","journal-title":"Vaccine"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1128\/IAI.72.7.4031-4039.2004","article-title":"Oral vaccination with Brucella melitensis<\/italic> WR201 protects mice against intranasal challenge with virulent Brucella melitensis<\/italic> 16M","volume":"72","author":"MJ Izadjoo","year":"2004","journal-title":"Infect Immun"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2015.06.006","article-title":"Protective immune-response of aluminium hydroxide gel adjuvanted phage lysate of Brucella abortus<\/italic> S19 in mice against direct virulent challenge with B<\/italic>. abortus<\/italic> 544","volume":"43","author":"L Jain","year":"2015","journal-title":"Biologicals"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","article-title":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus<\/italic> in BALB\/c mice","volume":"32","author":"S Jain","year":"2014","journal-title":"Vaccine"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11274-012-1247-3","article-title":"Immunological responses to recombinant cysteine synthase A of Brucella abortus<\/italic> in BALB\/c mice","volume":"29","author":"S Jain","year":"2013","journal-title":"World J Microbiol Biotechnol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1574-695X.12010","article-title":"Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis<\/italic> challenge in mice","volume":"66","author":"N Jain-Gupta","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/IAI.62.2.632-638.1994","article-title":"Protective immunity to Brucella ovis<\/italic> in BALB\/c mice following recovery from primary infection or immunization with subcellular vaccines","volume":"62","author":"MP Jim\u00e9nez de Bag\u00fc\u00e9s","year":"1994","journal-title":"Infect Immun"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1128\/IAI.62.11.4990-4996.1994","article-title":"Vaccination with Brucella abortus<\/italic> rough mutant RB51 protects BALB\/c mice against virulent strains of Brucella abortus<\/italic>, Brucella melitensis<\/italic>, and Brucella ovis<\/italic>","volume":"62","author":"MP Jim\u00e9nez de Bagu\u00e9s","year":"1994","journal-title":"Infect Immun"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1016\/j.vaccine.2010.06.023","article-title":"Inactivation of formyl transferase (wbkC) gene generates a Brucella abortus<\/italic> rough strain that is attenuated in macrophages and in mice","volume":"28","author":"TLS Lacerda","year":"2010","journal-title":"Vaccine"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.vaccine.2015.04.004","article-title":"Intermediate rough Brucella abortus<\/italic> S19\u0394per mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice","volume":"33","author":"J Lalsiamthara","year":"2015","journal-title":"Vaccine"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1099\/0022-1317-51-1-20","article-title":"Induction of a Th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus<\/italic> GroEL heat-shock gene","volume":"51","author":"S Leclerq","year":"2002","journal-title":"J Med Microbiol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2012.07.016","article-title":"Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus<\/italic> 544 infection in BALB\/c mice","volume":"161","author":"X Li","year":"2012","journal-title":"Vet Microbiol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4142\/jvs.2015.16.4.467","article-title":"Immunization of BALB\/c mice with Brucella abortus<\/italic> 2308\u0394wbkA confers protection against wild-type infection","volume":"16","author":"Z Li","year":"2015","journal-title":"J Vet Sci"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molimm.2015.04.004","article-title":"A Brucella melitensis<\/italic> M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy","volume":"66","author":"ZQ Li","year":"2015","journal-title":"Mol Immunol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4142\/jvs.2012.13.3.287","article-title":"Protective effects of recombinant Brucella abortus<\/italic> Omp28 against infection with a virulent strain of Brucella abortus<\/italic> 544 in mice","volume":"13","author":"JJ Lim","year":"2012","journal-title":"J Vet Sci"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.vetimm.2015.04.008","article-title":"Immune responses and protection induced by Brucella suis<\/italic> S2 bacterial ghosts in mice","volume":"166","author":"J Liu","year":"2015","journal-title":"Vet Immunol Immunopathol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus<\/italic> in BALB\/c Mice","volume":"74","author":"D Luo","year":"2006","journal-title":"Infect Immun"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1016\/j.vaccine.2007.09.008","article-title":"Escheriosome-mediated delivery of recombinant ribosomal L7\/L12 protein confers protection against murine brucellosis","volume":"25","author":"AI Mallick","year":"2007","journal-title":"Vaccine"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1297-9716-44-105","article-title":"Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis<\/italic> Rev 1 vaccine","volume":"44","author":"M Mancilla","year":"2013","journal-title":"BMC Vet Res"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis<\/italic> in mice with mannosylated nanoparticles","volume":"162","author":"RC Martins","year":"2012","journal-title":"J Control Release"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus<\/italic> O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus<\/italic> and Brucella ovis<\/italic> in the mouse model","volume":"71","author":"D Monreal","year":"2003","journal-title":"Infect Immun"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.53.2.245-251.1986","article-title":"Comparison of living and nonliving vaccines for Brucella abortus<\/italic> in BALB\/c mice","volume":"53","author":"JA Montaraz","year":"1986","journal-title":"Infect Immun"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.vaccine.2010.11.018","article-title":"Immunization of mice with gamma-irradiated Brucella neotomae<\/italic> and its recombinant strains induces protection against virulent B<\/italic>. abortus<\/italic>, B<\/italic>. melitensis<\/italic>, and B<\/italic>. suis<\/italic> challenge","volume":"29","author":"D Moustafa","year":"2011","journal-title":"Vaccine"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1128\/IAI.72.4.2081-2087.2004","article-title":"Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus<\/italic> induces SOD-specific CD4 and CD8 T Cells","volume":"72","author":"C Mu\u00f1oz-Montesino","year":"2004","journal-title":"Infect Immun"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0264-410X(01)00177-3","article-title":"A Brucella ovis<\/italic> antigenic complex bearing poly-\u03b5-caprolactone microparticles confer protection against experimental brucellosis in mice","volume":"19","author":"M Murillo","year":"2001","journal-title":"Vaccine"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus<\/italic> induces protective immunity in BALB\/c mice","volume":"71","author":"AA O\u00f1ate","year":"2003","journal-title":"Infect Immun"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/IAI.73.6.3294-3300.2005","article-title":"An RNA vaccine based on recombinant Semliki Forest Virus Particles Expressing the Cu,Zn superoxide dismutase protein of Brucella abortus<\/italic> induces protective immunity in BALB\/c mice","volume":"73","author":"AA O\u00f1ate","year":"2005","journal-title":"Infect Immun"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.67.2.986-988.1999","article-title":"Vaccination with live Escherichia coli<\/italic> expressing Brucella abortus<\/italic> Cu\/Zn superoxide dismutase protects mice against virulent B<\/italic>. abortus<\/italic>","volume":"67","author":"AA O\u00f1ate","year":"1999","journal-title":"Infect Immun"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcimb.2012.00035","article-title":"Immunogenic response of Brucella canis<\/italic> virB10 and virB11 mutants in a murine model","volume":"2","author":"E Palomares-Resendiz","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.0902209","article-title":"The protein moiety of Brucella abortus<\/italic> outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis","volume":"184","author":"KA Pasquevich","year":"2010","journal-title":"J Immunol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"e16203","DOI":"10.1371\/journal.pone.0016203","article-title":"An oral vaccine based on U-Omp19 induces protection against B<\/italic>. abortus<\/italic> mucosal challenge by inducing an adaptive IL-17 immune response in mice","volume":"6","author":"KA Pasquevich","year":"2011","journal-title":"PlosOne"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CVI.00653-14","article-title":"Immunization with Brucella<\/italic> VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs","volume":"22","author":"CN Pollak","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-1135(91)90053-I","article-title":"Unresponsiveness of vaccinated BALB\/c mice to a second inoculation of lipopolysaccharide from Brucella abortus<\/italic> strain 2308","volume":"26","author":"GW Pugh Jr","year":"1991","journal-title":"Vet Microbiol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1128\/CVI.00554-14","article-title":"Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus<\/italic> in mice","volume":"21","author":"A Retamal-D\u00edaz","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.vaccine.2013.06.013","article-title":"Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus<\/italic> in BALB\/c mice","volume":"31","author":"R Riquelme-Neira","year":"2013","journal-title":"Vaccine"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1128\/IAI.70.9.5036-5044.2002","article-title":"Identification and characterization of a Brucella abortus<\/italic> ATP-binding cassette transporter homolog to Rhizobium meliloti<\/italic> ExsA and its role in virulence and protection in mice","volume":"70","author":"GMS Rosinha","year":"2002","journal-title":"Infect Immun"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1099\/0022-1317-51-8-661","article-title":"Molecular and immunological characterisation of recombinant Brucella abortus<\/italic> glyceraldehyde-3- phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12-expressing plasmid in a DNA vaccine formulation","volume":"51","author":"GMS Rosinha","year":"2002","journal-title":"J Med Microbiol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/CDLI.12.12.1429-1436.2005","article-title":"Induction of antigen-specific Th1-Type immune responses by gamma-irradiated recombinant Brucella abortus<\/italic> RB51","volume":"12","author":"N Sanakkayala","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","article-title":"Biological properties of RB51; a stable rough strain of Brucella abortus<\/italic>","volume":"28","author":"GG Schurig","year":"1991","journal-title":"Vet Microbiol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/CVI.00191-15","article-title":"Protection provided by an encapsulated live attenuated \u0394abcBA strain of Brucella ovis<\/italic> against experimental challenge in a murine model","volume":"22","author":"AP Silva","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.vaccine.2015.04.030","article-title":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B<\/italic>. abortus<\/italic> 544 infection","volume":"33","author":"D Singh","year":"2015","journal-title":"Vaccine"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.micinf.2008.05.007","article-title":"Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus<\/italic>","volume":"10","author":"H Singha","year":"2008","journal-title":"Microbes Infect"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus<\/italic> 544 infection: A promising alternate to traditional adjuvants","volume":"68","author":"D Singh","year":"2015","journal-title":"Mol Immunol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1016\/j.vaccine.2012.09.039","article-title":"Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus<\/italic> in BALB\/c mice","volume":"30","author":"F Sislema-Egas","year":"2012","journal-title":"Vaccine"},{"key":"ref125","first-page":"2","article-title":"Mutants in the lipopolysaccharide of Brucella ovis<\/italic> are attenuated and protect against B<\/italic>. ovis<\/italic> infection in mice","volume":"45","author":"P Soler-Llor\u00e9ns","year":"2014","journal-title":"BMC Vet Res"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/IAI.02790-14","article-title":"Mutant Brucella abortus<\/italic> membrane fusogenic protein (BMFP) is highly attenuated and induces protection against challenge infection in mice","volume":"83","author":"JA Souza Filho","year":"2015","journal-title":"Infect Immun"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0264-410X(94)90035-3","article-title":"Modulation of immune responses in Balb\/c mice vaccinated with Brucella abortus<\/italic> Cu-Zn superoxide dismutase synthetic peptide vaccine","volume":"12","author":"LB Tabatabai","year":"1994","journal-title":"Vaccine"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/IAI.01433-09","article-title":"The Brucella abortus<\/italic> phosphoglycerate kinase mutant is highly attenuated and induces protection superior to that of vaccine strain 19 in immunocompromised and immunocompetent mice","volume":"78","author":"CGMC Trant","year":"2010","journal-title":"Infect Immun"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/CVI.00164-14","article-title":"Characterization and protective property of Brucella abortus<\/italic> cydC and looP mutants","volume":"21","author":"QL Truong","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","article-title":"Evaluation of Brucella abortus<\/italic> phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine","volume":"71","author":"JE Ugalde","year":"2003","journal-title":"Infect Immun"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus<\/italic> induces protective immunity in BALB\/c mice","volume":"70","author":"CA Velikovsky","year":"2002","journal-title":"Infect Immun"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s11274-012-1056-8","article-title":"Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus<\/italic> in BALB\/c mice","volume":"28","author":"SK Verma","year":"2012","journal-title":"World J Microbiol Biotechnol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3389\/fmicb.2015.01193","article-title":"Immunization with individual proteins of the Lrp\/AsnC family induces protection against Brucella melitensis<\/italic> 16M challenges in mice","volume":"6","author":"X Wang","year":"2015","journal-title":"Front Microbiol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.00573-12","article-title":"In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella<\/italic> spp","volume":"20","author":"Z Wang","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1128\/IAI.56.11.2808-2817.1988","article-title":"Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus<\/italic> in mice","volume":"56","author":"AJ Winter","year":"1988","journal-title":"Infect Immun"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molimm.2011.08.009","article-title":"Immunoproteomic analysis of Brucella melitensis<\/italic> and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine","volume":"49","author":"Y Yang","year":"2011","journal-title":"Mol Immunol"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.2010.00758.x","article-title":"Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis<\/italic> infection","volume":"61","author":"Y Yang","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD, and L7\/L12 confers high protection against Brucella abortus<\/italic> 2308 by inducing specific CTL responses","volume":"26","author":"DH Yu","year":"2007","journal-title":"DNA Cell Biol"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/1348-0421.12065","article-title":"Brucella melitensis<\/italic> 16M\u0394hfq attenuation confers protection against wild\u2010type challenge in BALB\/c mice","volume":"57","author":"J Zhang","year":"2013","journal-title":"Microbiol Immunol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12275-014-3689-9","article-title":"A potent Brucella abortus<\/italic> 2308 \u0394ery live vaccine allows for the differentiation between natural and vaccinated infection","volume":"52","author":"J Zhang","year":"2014","journal-title":"J Microbiol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.vaccine.2009.06.075","article-title":"Protection of mice from Brucella<\/italic> infection by immunization with attenuated Salmonella enterica<\/italic> serovar typhimurium expressing A L7\/L12 and BLS fusion antigen of Brucella<\/italic>","volume":"27","author":"Z Zhao","year":"2009","journal-title":"Vaccine"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/IAI.71.5.2326-2330.2003","article-title":"Brucella abortus<\/italic> RB51 induces protection in mice orally infected with the virulent strain B<\/italic>. abortus<\/italic> 2308","volume":"71","author":"P Pasquali","year":"2003","journal-title":"Infect Immun"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(02)00252-3","article-title":"Epidemiology and control of brucellosis in China","volume":"90","author":"S Deqiu","year":"2002","journal-title":"Vet Microbiol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of Brucella melitensis<\/italic> Rev. 1 vaccine in adult sheepand goats","volume":"31","author":"JM Blasco","year":"1997","journal-title":"Prev Vet Med"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7883\/yoken.63.8","article-title":"Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments","volume":"63","author":"S Tamura","year":"2010","journal-title":"Jpn J Infect Dis"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"e114532","DOI":"10.1371\/journal.pone.0114532","article-title":"The predicted ABC transporter AbcEDCBA is required for type IV secretion system expression and lysosomal evasion by Brucella ovis<\/italic>","volume":"9","author":"TMA Silva","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref147","doi-asserted-by":"crossref","first-page":"e0138131","DOI":"10.1371\/journal.pone.0138131","article-title":"The abcEDCBA-encoded ABC transporter and the virB operon-encoded type IV secretion system of Brucella ovis<\/italic> are critical for intracellular trafficking and survival in ovine monocyte-derived macrophages","volume":"10","author":"AA Mac\u00eado","year":"2015","journal-title":"PLoS One"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"e0136865","DOI":"10.1371\/journal.pone.0136865","article-title":"Encapsulated Brucella ovis<\/italic> lacking a putative ATP-binding cassette transporter (\u0394abcBA) protects against wild type Brucella ovis<\/italic> in Rams","volume":"10","author":"APC Silva","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 4","key":"ref149","first-page":"D40","article-title":"Brucellosis: the case for live, attenuated vaccines","volume":"2009","author":"TA Ficht","journal-title":"Vaccine"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1016\/j.vaccine.2006.04.020","article-title":"Efficacy of strain RB51 vaccine in heifers against experimental brucellosis","volume":"24","author":"FP Poester","year":"2006","journal-title":"Vaccine"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1741e9","DOI":"10.1016\/j.vaccine.2009.01.025","article-title":"Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis<\/italic> infection of sheep","volume":"27","author":"MB Barrio","year":"2009","journal-title":"Vaccine"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/IAI.26.2.680-685.1979","article-title":"Comparison of Brucella abortus<\/italic> and Brucella melitensis<\/italic> infections of mice and their effect on acquired cellular resistance","volume":"26","author":"EJ Young","year":"1979","journal-title":"Infect Immun"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/IAI.68.7.4102-4107.2000","article-title":"Identification of genes required for chronic persistence of Brucella abortus<\/italic> in mice","volume":"68","author":"PC Hong","year":"2000","journal-title":"Infect Immun"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1128\/IAI.01787-05","article-title":"Evaluation of protection afforded by Brucella abortus<\/italic> and Brucella melitensis<\/italic> unmarked deletion mutants exhibiting different rates of clearance in BALB\/c mice","volume":"74","author":"MM Kahl-McDonagh","year":"2006","journal-title":"Infect Immun"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/IAI.66.3.1008-1016.1998","article-title":"Transposon-derived Brucella abortus<\/italic> rough mutants are attenuated and exhibit reduced intracellular survival","volume":"66","author":"CA Allen","year":"1998","journal-title":"Infect Immun"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0378-1135(02)00216-X","article-title":"Discovery of Brucella<\/italic> virulence mechanisms using mutational analysis","volume":"90","author":"TA Ficht","year":"2002","journal-title":"Vet Microbiol"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1135(00)00225-X","article-title":"Attenuation and immunogenicity of a Brucella abortus<\/italic> htrA cycL double mutant in cattle","volume":"76","author":"M Edmonds","year":"2000","journal-title":"Vet Microbiol"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vetmic.2008.05.003","article-title":"Protection levels in vaccinated heifers with experimental vaccines Brucella abortus<\/italic> M1-luc and INTA 2","volume":"132","author":"MA Fiorentino","year":"2008","journal-title":"Vet Microbiol"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.drudis.2008.04.010","article-title":"Vaccines against intracellular bacterial pathogens","volume":"13","author":"RW Titball","year":"2008","journal-title":"Drug Discov Today"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcimb.2013.00017","article-title":"Host-Brucella<\/italic> interactions and the Brucella<\/italic> genome as tools for subunit antigen discovery and immunization against brucellosis","volume":"3","author":"G Gomez","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3168\/jds.2009-2140","article-title":"Invited review: Use of meta-analysis in animal health and reproduction: methods and applications","volume":"92","author":"IJ Lean","year":"2009","journal-title":"J Dairy Sci"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1297-9716-43-29","article-title":"What have we learned from brucellosis in the mouse model?","volume":"43","author":"MJ Grill\u00f3","year":"2012","journal-title":"Vet Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T16:21:58Z","timestamp":1718900518000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166582"}},"subtitle":[],"editor":[{"given":"Roy Martin","family":"Roop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":163,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166582","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}